Rahul Banerjee/X
Aug 7, 2024, 01:13
Rahul Banerjee’s perspectives on approval of daratumumab and hyaluronidase plus VRd in MM
Oncology Data Advisor shared on X:
“Did you hear about last week’s approval of daratumumab and hyaluronidase plus VRd as ASCT induction and consolidation for newly diagnosed multiple myeloma (NDMM)?
Read Rahul Banerjee’s perspectives and comment your thoughts below!”
Source: Oncology Data Advisor/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56
Nov 13, 2024, 15:46
Nov 13, 2024, 15:32
Nov 13, 2024, 15:29